Overview

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.

Status:
Unknown status
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the diagnostic value of the Aldosterone-Renin Ratio (ARR)as a screening test for primary aldosteronism among hypertensives. The test characteristics will be studied. Furthermore, the effect of eplerenone, a selective aldosterone-receptor antagonist will be studied.
Details
Lead Sponsor:
Erasmus Medical Center
Collaborators:
Dutch Kidney Foundation
Pfizer
Treatments:
Eplerenone